In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Puritan Bennett

Division of Medtronic PLC
www.mallinckrodt.com

Latest From Puritan Bennett

Industry In Focus: US Home Health Care Revenues Set to Exceed $5 Billion by 2012

The US home health care market, valued at nearly $4.5 billion in 2009, is set to experience steady growth in the years ahead, driven by a burgeoning aging population, a critical need for cost-effective solutions for patients suffering from long-term chronic conditions, and the increasing use of technology to meet the needs of those receiving home-based medical care. According to Medtech Insight's recent report "US Markets for Home Health Care Products," sales revenues for the major home health care product segments are expected to reach $5.2 billion by 2012.

Deals Shaping the Medical Industry (9/06)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

Sleep Apnea: The Market Behind the Mask

Sleep is getting a lot of attention in the clinical community these days, and in particular, interrupted sleep. The obstructive sleep apnea market for treatment, monitoring and diagnostic products is forecast to grow at an almost 13% compound annual growth rate through the year 2010 based on only incremental changes to existing diagnostic and treatment modalities, according to "US Markets for Blood Gas/Electrolyte Monitoring, Pulmonary Function Assessment, and Sleep Apnea Management Products," published in December 2005 by Medtech Insight. But the field is beginning to see an influx of new kinds of treatments from both the medical device and pharmaceutical industries as well.
Medical Device

Emergent Respiratory Products Inc.

Emergent Respiratory Products Inc.'s non-invasive ventilation technology delivers pressure on demand. Its CPAPos system isn't continuous--oxygen flows only when patients inhale, thus conserving oxygen use and increasing patient comfort.
Medical Device
See All
Advertisement
Advertisement
UsernamePublicRestriction

Register